SEC Company Response from Summit Therapeutics Inc. (SMMT) (CIK 0001599298) (SMMT) — Mar 2, 2015
Summit Therapeutics Inc. (SMMT) (CIK 0001599298)
Date: March 2, 2015 · CIK: 0001599298 · Accession: 0001193125-15-073309
AI Filing Summary & Sentiment
File numbers found in text: 333-201807
Letter
Re: Summit Therapeutics plc
SEC Letter
March 2, 2015
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-4720
Form F-1 Registration Statement
File No. 333-201807
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join Summit Therapeutics plc in requesting that the effective date of the above-referenced registration statement be accelerated to Wednesday March 4, 2015, at 4:00 p.m., Eastern time, or as soon thereafter as practicable.
In connection with this acceleration request and pursuant to Rule 460 under the Act, please be advised that from February 20, 2015 through the date hereof, the undersigned effected the following approximate distribution of copies of the Preliminary Prospectus dated February 20, 2015:
- 0 to prospective underwriters;
- 421 to institutional investors;
- 0 to prospective dealers; and
- 959 to others (including individuals).
This is to further advise you that the underwriters have complied and will continue to comply with SEC release No. 33-4968 and Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
JMP SECURITIES LLC
Show Raw Text
CORRESP 1 filename1.htm SEC Letter March 2, 2015 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549-4720 Re: Summit Therapeutics plc Form F-1 Registration Statement File No. 333-201807 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join Summit Therapeutics plc in requesting that the effective date of the above-referenced registration statement be accelerated to Wednesday March 4, 2015, at 4:00 p.m., Eastern time, or as soon thereafter as practicable. In connection with this acceleration request and pursuant to Rule 460 under the Act, please be advised that from February 20, 2015 through the date hereof, the undersigned effected the following approximate distribution of copies of the Preliminary Prospectus dated February 20, 2015: - 0 to prospective underwriters; - 421 to institutional investors; - 0 to prospective dealers; and - 959 to others (including individuals). This is to further advise you that the underwriters have complied and will continue to comply with SEC release No. 33-4968 and Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Remainder of Page Intentionally Left Blank] Very truly yours, JMP SECURITIES LLC By: /s/ Gil Mogavero Name: Title: Gil Mogavero Managing Director OPPENHEIMER & CO. INC. By: /s/ Douglas Cameron Name: Title: Douglas Cameron Managing Director For themselves and as Representatives of the several Underwriters 2